Frank Rimerman Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Frank Rimerman Advisors's GSK Position: Q3 2026 in Review
Frank Rimerman Advisors reduced its GSK (GSK) stake by 4.5% in Q3 2026, selling an estimated $33.4K and leaving 13,916 shares worth $670K. The position accounts for 0.04% of the portfolio, ranked #342.
Frank Rimerman Advisors first reported a position in GSK in Q2 2024 and has held it in 7 quarters since. The position peaked at $843K in Q1 2026. 981 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Frank Rimerman Advisors held 13,916 shares of GSK worth $670K as of Q3 2026.
- Frank Rimerman Advisors sold 654 GSK shares in Q3 2026, an estimated $33.4K.
- GSK made up 0.04% of Frank Rimerman Advisors's portfolio in Q3 2026, its #342 holding.
- Frank Rimerman Advisors first reported a position in GSK in Q2 2024 and has held it in 7 quarters since.
- Frank Rimerman Advisors's GSK position peaked at $843K in Q1 2026.
- 981 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Frank Rimerman Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.